Here are relevant reports on : occupational-health-safety-market

• Passenger Car Active & Passive Safety Systems Market - By Type, Technology & Geography (2014 - 2019)

  • Published: December 2026
  • Price: $ 4950
  • TOC Available:

• Passive Safety Systems Market - 2019 By Type, Technology & Geography

  • Published: December 2026
  • Price: $ 4950
  • TOC Available:

• Food as Medicine Market By Product Type (Functional Foods, Medical Foods, Nutraceuticals, Personalized Nutrition Products, Therapeutic Food Products), Function (Metabolic Health, Diabetes Management, Cardiovascular Health, Gastrointestinal Health, Immune Health, Other Functions), Ingredient Type, Source, Form, Distribution Channel, Prescription Type (Qualitative), and Region – Global Forecast to 2031

  The food as medicine market is estimated at USD 254.15 billion in 2026 and is projected to reach USD 400.81 billion by 2031, at a CAGR of 9.5% from 2026 to 2031 The Key Players Nestlé Health Science (Switzerland), Danone (France), Abbott Nutrition (US), Reckitt Mead Johnson (UK), FrieslandCampina (Netherlands), Herbalife (US), Amway (US), Novonesis (Denmark), Yakult Honsha Co., Ltd. (Japan), Unilever (UK), Otsuka Holdings (Japan), Probi AB (Sweden), Church & Dwight Co., Inc. (US), Meiji Holdings (Japan), and Jamieson Wellness (Canada).

  • Published: December 2026
  • Price: $ 4950
  • TOC Available:

• Car Safety Market by System Type (Active Safety & Passive Safety), Safety Regulations by Region (APAC, Europe, North America & Rest of the World), Impact Analysis (Overall Market OEM, Tier I & Consumer) - Trends & Forecast to 2020

  The car safety systems market is estimated to be USD 93.73 Billion in 2015, and is projected to reach 152.59 Billion by 2020, growing at a CAGR of 10.24%. The car safety systems market has witnessed considerable growth in countries such as the U.S., China, India, and Mexico, owing to the increasing vehicle electrification, rising vehicle production, and increasingly stringent safety norms.

  • Published: January 2016
  • Price: $ 4950
  • TOC Available:

• Asia Pacific Patient Engagement Solutions Market by Therapy (Chronic [Obesity, Diabetes], Women’s Health), Functionality (Telehealth, E-Prescribing, Scheduling, Billing), End User (Hospital, ASC, Payer, Patient), Unmet Need, Investment - Forecast to 2030

  The Asia Pacific Patient Engagement Solutions market, valued at USD 3.45 billion in 2024, stood at USD 3.97 billion in 2025 and is projected to advance at a resilient CAGR of 13.5% from 2025 to 2030, culminating in a forecasted valuation of USD 7.48 billion by the end of the period. This growth is driven by the rising demand for patient-centered and personalized care, a rapid expansion of telehealth and remote care frameworks, and more investments in digital healthcare infrastructure within the Asia Pacific region.

  • Published: November 2026
  • Price: $ 4950
  • TOC Available:

• Precision Biotics Market by Type (Precision Probiotics, Next-generation Probiotics, Synbiotics, Postbiotics), End-use Industry, Health/Functional Positioning, Distribution Channel, and Region - Global Forecast to 2031

  The precision biotics market is estimated at USD 4.91 billion in 2026 and is projected to reach USD 9.26 billion by 2031, at a CAGR of 13.5% from 2026 to 2031. The report profiles key players such as BioGaia (Sweden), Novonesis Group (Denmark), Procter & Gamble (US), Unilever (UK), dsm-firmenich (Switzerland), Metagenics, LLC (US), Yakult Honsha Co., Ltd (Japan), Danone (France), KANEKA CORPORATION (Japan), Symrise (Germany)-(Probi), Jarrow Formulas, Inc (US), Pendulum (US), thegoodbug (India), Seed Health, Inc (US), and Infinant Health Inc (US).

  • Published: July 2026
  • Price: $ 4950
  • TOC Available:

• Pet Supplements Market by Functional Application (Skin & Coat, Hips & Joints, Digestive Health, Immune Support), Supplement Type (Multivitamin, Glucosamine, Antioxidants), Pet, Form, Distribution Channel, and Region - Global Forecast to 2029

  According to MarketsandMarkets, the global pet supplements market is estimated to be valued at USD XXX.X million in 2024 and is projected to reach USD XXX.X million by 2029, recording a CAGR of X.X%. Key players in this market include ADM (US), Nestlé (Switzerland), Nutramax Laboratories, Inc. (US), Zoetis Services LLC (US), Virbac (France), Zesty Paws (US), These players have adopted strategies of product launches, expansions, agreements/partnerships, and mergers and acquisitions to grow in the market. All key product manufacturers that are part of the pet supplements ecosystem have been considered under the company profiles section.

  • Published: December 2026
  • Price: $ 4950
  • TOC Available:

• Prostate Health Market by Disease Indication (Prostate Cancer, PARP Inhibitors, Cytotoxic Drug, Benign Prostate Hyperplasia (BPH), Tamsulosin, 5 Alpha Reductase, Prostatitis, OTC, Prescription (Rx), & Region (NA, Europe, APAC) - Global Forecast to 2026

  The global prostate health market growth is primed to transition from USD 31.8 billion in 2021 to USD 48.9 billion by 2026, showcasing a strong CAGR of 9.0%. Growth in this market is primarily driven by the increasing prevalence of benign prostatic hyperplasia, increasing obesity, investments, funds, and grants for research in prostate health, an increase in the prevalence of prostate cancer, a surge in demand for hormone therapy drugs, emerging therapies for prostate cancer, and an increasing incidence of prostatitis.

  • Published: December 2021
  • Price: $ 4950
  • TOC Available:

• Corporate Wellness Solutions Market by Service Offering (HRA, Nutrition, Weight Loss, Fitness, Substance Abuse Management, Employee Assistance Programs, Health Benefits), End User (Organizations (Large, Mid-Sized, SME)) & Region - Global Forecast to 2026

  The global corporate wellness solutions market in terms of revenue was estimated to be worth $61.2 billion in 2021 and is poised to reach $94.6 billion by 2026, growing at a CAGR of 9.1% from 2021 to 2026. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market.

  • Published: June 2021
  • Price: $ 4950
  • TOC Available:

• Wearables in Pharma & Biotech Market by Product (Smartwatches, CGMs, Bands, Rings, Patches, Injectors), Therapy (Diabetes, Cardio, Onco, Mental Health), Application (Drug Discovery, Clinical Trials, Medication Adherence), End User - Global Forecasts to 2031

  The global wearables in pharma & biotech market is projected to reach USD 9.97 billion by 2031, growing at a CAGR of 20.2% during the forecast period (2026–2031). The report covers key segments, regional analysis, and competitive landscape across the market ecosystem.

  • Published: April 2026
  • Price: $ 4950
  • TOC Available:

• FIRST
• PREVIOUS

Records 41 to 50 of 50